Levosemotiadil
Grundinformationen
- CAS
116476-16-5- Standard-SMILES
COc1ccc(OCCCN(C)CCOc2ccc3c(c2)OCO3)c([C@@H]2Sc3ccccc3N(C)C2=O)c1- InChIKey
RKXVEXUAWGRFNP-NDEPHWFRSA-N- Summenformel
- C29H32N2O6S
- Durchschnittliche Molmasse
- 536,6 g/mol
- Monoisotopische Masse
- 536,19810792
Überblick
Levosemotiadil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Levosemotiadil is a vasodilator. Levosemotiadil has a monoisotopic molecular weight of 536.2 Da.
Namen und Bezeichner
- Bevorzugter Name
- Levosemotiadil
- IUPAC
- (2S)-2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-one
- Englischer Name
- Levosemotiadil
- Summenformel
- C29H32N2O6S
- Molmasse
- 536.64
Namen und Synonyme
Levosemotiadil116476-16-59VDH1G55NCDTXSID401036181(-)-(S)-2-(5-Methoxy-2-(3-(methyl(2-(3,4-(methylenedioxy)phenoxy)ethyl)amino)propoxy)phenyl)-4-methyl-2H-1,4-benzothiazin-3(4H)-onelevosemotiadilumRefChem:153232DTXCID701520393Levosemotiadil [INN](2S)-2-[2-[3-[2-(1,3-benzodioxol-5-yloxy)ethyl-methylamino]propoxy]-5-methoxyphenyl]-4-methyl-1,4-benzothiazin-3-oneUNII-9VDH1G55NCSCHEMBL678293
Weitere Namen anzeigen
Reaxys ID: 35797562H-1,4-Benzothiazin-3(4H)-one, 2-[2-[3-[[2-(1,3-benzodioxol-5-yloxy)ethyl]methylamino]propoxy]-5-methoxyphenyl]-4-methyl-, (2S)-[2S,(-)]-3,4-Dihydro-2-[5-methoxy-2-[3-[methyl[2-[(1,3-benzodioxol-5-yl)oxy]ethyl]amino]propoxy]phenyl]-4-methyl-2H-1,4-benzothiazin-3-one
orb1702032CHEMBL2105033AKOS040747071(S)-2-(2-(3-((2-(benzo[d][1,3]dioxol-5-yloxy)ethyl)(methyl)amino)propoxy)-5-methoxyphenyl)-4-methyl-2H-benzo[b][1,4]thiazin-3(4H)-oneHY-121535CS-0082703T25701Q27273280
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 5,1
- Polarare Oberfläche (TPSA)
- 95 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 8
- Frei drehbare Bindungen
- 11
- Schwere Atome
- 38
- Formalladung
- 0
- Komplexität
- 761
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
Anbieter5 Anbieter
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
济南思考化学有限公司0531-0000 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
TargetMol中国（陶术生物）15002134094 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…